BLOODPAC organizes and takes part in events that amplify the promise of liquid biopsy science. As an organization we leverage our collaborative infrastructure to bring together stakeholders in public, industry, academia and regulatory agencies to discuss the most vital issues affecting the liquid biopsy space.
This seminar explores advancements in multi-omics and AI-driven approaches in liquid biopsy.
In this virtual seminar, leading experts from academia and industry presented their work on a broad range of CHIP research.
Five years after the launch of BLOODPAC, members came together to reflect on our journey and discuss the goals we’ve set for our next chapter.
Panel discussion “Improving Cancer Care Requires Payers at the Table”. Presentation “Analytical Validation Continued, BLOODPAC’s Generic MRD Protocol”.
We are thrilled to announce that BLOODPAC's in-person 2025 Q1 meeting will be hosted by Natera in Austin, TX this March!
Presentation “Enhancing Collaboration & Harmonization in Liquid Biopsy Surveillance: A BLOODPAC Perspective”.
Exploring the power of global collaboration in advancing liquid biopsy access for patients worldwide.
Seminar: the evolving role of artificial intelligence (AI) and advanced multi-omics technologies in transforming the liquid biopsy landscape.
Enhancing Collaboration & Harmonization in Liquid Biopsy Surveillance: A BLOODPAC Perspective
Panel Discussion: Liquid Biopsy - Recent Developments
BLOODPAC will be hosting a dinner on the evening of Friday, September 13, 2024, in Barcelona, Spain, during the ESMO Congress 2024.
We are thrilled to announce that BLOODPAC's in-person Q3 2024 meeting will be hosted by Personalis in Fremont, CA, this September!
